Arcoxia contains the active ingredient etoricoxib. It is also known by its medical name, etoricoxib, and other brand names like Tauxib. Arcoxia is used to reduce pain and inflammation in conditions like arthritis, osteoarthritis, and gout.
The pricing structure for Arcoxia is set between £0.53 and £1.12 for every pills. It’s reflective of the size of the packaging and ingredient concentration (30 or 360 mg).
Arcoxia is a brand name for the drug etoricoxib, which belongs to the class of medications known as selective COX-2 inhibitors or NSAIDs. It is primarily used for the treatment of various forms of arthritis and pain management. By selectively inhibiting the enzyme cyclooxygenase-2 (COX-2), Arcoxia helps reduce inflammation and pain without affecting the COX-1 enzyme, which protects the stomach lining.
Arcoxia is available in tablet form and comes in different strengths: 30 mg, 60 mg, 90 mg, and 120 mg. The strength and dosage are typically determined by the specific medical condition being treated and the patient’s response to the medication. The tablets are film-coated and should be swallowed whole with water.
For osteoarthritis, the recommended dose is 30 mg or 60 mg once daily. For rheumatoid arthritis, a dose of 90 mg once daily is recommended. For ankylosing spondylitis, the typical dose is 90 mg once daily. For acute pain and gout, a dose of 120 mg once daily is advised, but only for the shortest possible duration.
Arcoxia is indicated for the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis. It is also prescribed for short-term management of moderate pain associated with dental surgery or primary dysmenorrhea. Its efficacy in managing chronic pain conditions has been well documented in clinical trials.
Arcoxia exerts its effects by selectively inhibiting the COX-2 enzyme, thereby reducing the production of prostaglandins, which are responsible for inflammation and pain. Unlike traditional NSAIDs, Arcoxia does not inhibit the COX-1 enzyme, thus minimizing gastrointestinal side effects such as ulcers or bleeding.
After oral administration, Arcoxia is rapidly absorbed, with peak plasma concentrations reached within 1-2 hours. The medication is metabolized in the liver predominantly by the CYP3A4 enzyme and has a half-life of approximately 22 hours. This allows for once-daily dosing. The elimination of the drug occurs primarily through renal excretion.
Arcoxia is contraindicated in patients with hypersensitivity to etoricoxib or any components of the tablet. It should not be used in patients with active peptic ulceration, inflammatory bowel disease, or severe congestive heart failure. Additionally, Arcoxia is contraindicated in patients with significant renal or hepatic impairment.
Arcoxia can interact with various medications. For example, it may increase the effects of anticoagulants like warfarin, enhancing the risk of bleeding. Concurrent use with ACE inhibitors, diuretics, or beta-blockers may result in diminished antihypertensive effects. Co-administration with other NSAIDs or corticosteroids may escalate gastrointestinal risks.
Special caution is advised when prescribing Arcoxia to elderly patients due to an increased risk of adverse reactions. For patients with mild to moderate hepatic impairment, a lower dose is recommended. Its safety and efficacy in pediatric patients have not been established, and it is generally not prescribed in this age group. Lactating mothers should exercise caution as the drug may pass into breast milk.
Arcoxia tablets should be taken orally once daily, with or without food. Patients are advised to swallow the tablet whole, not to crush or chew it, and to follow their prescribed dosage strictly. Missed doses should be taken as soon as remembered unless it is close to the time for the next dose, in which case the missed dose should be skipped.
Arcoxia tablets should be stored at room temperature, between 20°C and 25°C (68°F and 77°F), in their original packaging to protect from moisture. The medication should be kept out of reach of children and should not be used beyond its expiration date.
Common side effects include headache, dizziness, gastrointestinal discomfort, and hypertension. Less common but serious side effects can include edema, heart failure, and severe liver dysfunction. If any serious adverse effects are observed, medical advice should be sought immediately.
Regular monitoring of blood pressure is advised, especially in patients with hypertension. Liver function tests and renal function tests should be performed periodically to detect any potential hepatotoxicity or nephrotoxicity. Patients with cardiovascular disease should be closely monitored for any signs of heart failure or thrombotic events.
Clinical trials have demonstrated Arcoxia’s efficacy in reducing inflammation and pain associated with osteoarthritis, rheumatoid arthritis, and other forms of arthritis. These studies have highlighted its relatively favorable gastrointestinal safety profile compared to traditional NSAIDs, owing to its COX-2 selectivity.
Patients should be advised to take the medication as prescribed and to report any side effects to their healthcare provider. They should be informed of the potential risks associated with long-term NSAID use and the importance of adhering to the recommended dosage to minimize adverse effects. Patients should also be aware of the potential drug interactions and inform their healthcare provider of all medications they are currently taking.